Given the important roles of miR‐194 cluster genes in repressing CUL4B and inhibiting tumor progression in NSCLC, miR‐194 mimics should be explored as a potential therapeutic agent. This evidence concerns the gene CUL4B and non-small cell lung carcinoma.